Cerebellum’s Merck MRK Stock Holding History

Cerebellum’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35	Closed	-$3K	–	490
2019 Q1	$3K	Buy	+35	New	+$2.62K	﹤0.01%	420

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cerebellum's MRK Position: Q2 2019 in Review

Cerebellum sold out of Merck (MRK) in Q2 2019, closing a stake of 35 shares — an estimated $3K sold.

Cerebellum first reported a position in MRK in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

Cerebellum reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
Cerebellum sold 35 Merck shares in Q2 2019, an estimated $3K.
Cerebellum first reported a position in Merck in Q1 2019 and held it in 1 quarter.
Cerebellum's Merck position peaked at $3K in Q1 2019.
2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Cerebellum's 13F filing for Q2 2019, filed 19 Jul 2019.